| neuronal action potential | GO:0019228 | 54 | 0.491 | |
| negative regulation of ovulation | GO:0060280 | 1 | 0.430 | |
| action potential | GO:0001508 | 78 | 0.394 | |
| skeletal system development | GO:0001501 | 356 | 0.389 | |
| negative regulation of metanephric glomerulus development | GO:0072299 | 1 | 0.327 | |
| epithelial cell development | GO:0002064 | 159 | 0.324 | |
| adrenal cortex development | GO:0035801 | 2 | 0.322 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.319 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.293 | |
| adrenal cortex formation | GO:0035802 | 2 | 0.238 | |
| negative regulation of metanephric glomerular mesangial cell proliferation | GO:0072302 | 1 | 0.233 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.229 | |
| schwann cell differentiation | GO:0014037 | 26 | 0.213 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.181 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.178 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.175 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.171 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.169 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.166 | |
| metanephric part of ureteric bud development | GO:0035502 | 2 | 0.157 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.156 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.156 | |
| gland development | GO:0048732 | 330 | 0.149 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.142 | |
| urogenital system development | GO:0001655 | 261 | 0.141 | |
| regulation of cell activation | GO:0050865 | 289 | 0.137 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.135 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.135 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.132 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.123 | |
| skin development | GO:0043588 | 220 | 0.117 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.116 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.116 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.113 | |
| intracellular protein transport | GO:0006886 | 204 | 0.113 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.111 | |
| cell fate commitment | GO:0045165 | 210 | 0.110 | |
| glial cell differentiation | GO:0010001 | 131 | 0.109 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.108 | |
| regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061418 | 2 | 0.107 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.107 | |
| myelination | GO:0042552 | 74 | 0.106 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.103 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.102 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.102 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.102 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.102 | |
| bone development | GO:0060348 | 120 | 0.100 | |
| regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900211 | 4 | 0.100 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.099 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.098 | |
| epidermis development | GO:0008544 | 187 | 0.097 | |
| synaptic transmission | GO:0007268 | 329 | 0.097 | |
| cell maturation | GO:0048469 | 127 | 0.096 | |
| protein export from nucleus | GO:0006611 | 20 | 0.096 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.095 | |
| actin filament organization | GO:0007015 | 113 | 0.095 | |
| respiratory system development | GO:0060541 | 190 | 0.093 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.092 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.092 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.092 | |
| camera type eye development | GO:0043010 | 266 | 0.091 | |
| gtp metabolic process | GO:0046039 | 144 | 0.091 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.090 | |
| regulation of protein localization | GO:0032880 | 231 | 0.090 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.089 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.089 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.088 | |
| mapk cascade | GO:0000165 | 281 | 0.087 | |
| developmental maturation | GO:0021700 | 193 | 0.087 | |
| axon ensheathment | GO:0008366 | 76 | 0.086 | |
| rhombomere 3 formation | GO:0021660 | 1 | 0.086 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.084 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.084 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.084 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.084 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.083 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.083 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.083 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.081 | |
| gliogenesis | GO:0042063 | 141 | 0.081 | |
| endocytosis | GO:0006897 | 168 | 0.081 | |
| cytokine production | GO:0001816 | 319 | 0.080 | |
| bone morphogenesis | GO:0060349 | 78 | 0.078 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.076 | |
| apical constriction | GO:0003383 | 4 | 0.075 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.075 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.074 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.074 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.074 | |
| wound healing | GO:0042060 | 157 | 0.073 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.073 | |
| chemotaxis | GO:0006935 | 247 | 0.073 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.073 | |
| germ cell development | GO:0007281 | 185 | 0.071 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.071 | |
| rhombomere 3 morphogenesis | GO:0021658 | 2 | 0.071 | |
| fertilization | GO:0009566 | 127 | 0.071 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.069 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.069 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.069 | |
| protein processing | GO:0016485 | 163 | 0.068 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.068 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.067 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.067 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.066 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.066 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.066 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.066 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.066 | |
| organ growth | GO:0035265 | 117 | 0.065 | |
| renal system development | GO:0072001 | 225 | 0.065 | |
| glial cell development | GO:0021782 | 54 | 0.065 | |
| sensory system development | GO:0048880 | 3 | 0.065 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.063 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.063 | |
| amine metabolic process | GO:0009308 | 45 | 0.063 | |
| response to peptide hormone | GO:0043434 | 127 | 0.063 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.063 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.062 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.061 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.061 | |
| regulation of transcription from rna polymerase iii promoter | GO:0006359 | 2 | 0.061 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.061 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.060 | |
| compound eye development | GO:0048749 | 1 | 0.060 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.060 | |
| digestive tract development | GO:0048565 | 190 | 0.060 | |
| lateral line system development | GO:0048925 | 1 | 0.060 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.059 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.059 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.059 | |
| regulation of glomerular mesangial cell proliferation | GO:0072124 | 1 | 0.058 | |
| t cell activation | GO:0042110 | 289 | 0.058 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.057 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.057 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.057 | |
| rhombomere 5 development | GO:0021571 | 4 | 0.057 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.055 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.054 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.054 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.054 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.054 | |
| gamma delta t cell differentiation | GO:0042492 | 11 | 0.054 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.053 | |
| membrane organization | GO:0061024 | 245 | 0.053 | |
| protein localization to organelle | GO:0033365 | 185 | 0.053 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.052 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.052 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.052 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.051 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.051 | |
| muscle tissue development | GO:0060537 | 308 | 0.051 | |
| nephron epithelium development | GO:0072009 | 92 | 0.051 | |
| regulation of mesonephros development | GO:0061217 | 24 | 0.050 | |
| nephron development | GO:0072006 | 109 | 0.050 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.050 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.050 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.050 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.050 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.049 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.049 | |
| rhombomere 3 development | GO:0021569 | 4 | 0.049 | |
| mitochondrion distribution | GO:0048311 | 4 | 0.049 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.049 | |
| organelle localization | GO:0051640 | 179 | 0.049 | |
| negative regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900212 | 4 | 0.049 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.049 | |
| regulation of protein transport | GO:0051223 | 163 | 0.048 | |
| oocyte construction | GO:0007308 | 2 | 0.048 | |
| seminiferous tubule development | GO:0072520 | 14 | 0.048 | |
| female sex differentiation | GO:0046660 | 84 | 0.048 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.048 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.048 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.048 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.047 | |
| nuclear transport | GO:0051169 | 139 | 0.047 | |
| regulation of translation | GO:0006417 | 71 | 0.047 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.047 | |
| stem cell development | GO:0048864 | 219 | 0.047 | |
| regulation of actin filament polymerization | GO:0030833 | 38 | 0.047 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.047 | |
| learning or memory | GO:0007611 | 148 | 0.046 | |
| regulation of cell migration | GO:0030334 | 219 | 0.046 | |
| diaphragm development | GO:0060539 | 5 | 0.046 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.045 | |
| endocrine system development | GO:0035270 | 98 | 0.045 | |
| protein catabolic process | GO:0030163 | 221 | 0.045 | |
| endomembrane system organization | GO:0010256 | 147 | 0.045 | |
| spermatogenesis | GO:0007283 | 284 | 0.045 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.045 | |
| stem cell differentiation | GO:0048863 | 268 | 0.045 | |
| cellular response to lipid | GO:0071396 | 145 | 0.045 | |
| heart morphogenesis | GO:0003007 | 178 | 0.045 | |
| microtubule based process | GO:0007017 | 236 | 0.044 | |
| actin filament polymerization | GO:0030041 | 44 | 0.044 | |
| blastoderm segmentation | GO:0007350 | 13 | 0.044 | |
| sperm motility | GO:0030317 | 47 | 0.044 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.044 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.044 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.043 | |
| kidney development | GO:0001822 | 213 | 0.043 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.043 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.043 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.043 | |
| ossification | GO:0001503 | 216 | 0.042 | |
| male gonad development | GO:0008584 | 88 | 0.042 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.042 | |
| regulation of heart growth | GO:0060420 | 31 | 0.042 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.042 | |
| gtp catabolic process | GO:0006184 | 143 | 0.042 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.042 | |
| gastrulation | GO:0007369 | 116 | 0.041 | |
| positive regulation of male gonad development | GO:2000020 | 6 | 0.041 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.041 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.041 | |
| primary neural tube formation | GO:0014020 | 95 | 0.041 | |
| axon guidance | GO:0007411 | 141 | 0.041 | |
| positive regulation of integrin mediated signaling pathway | GO:2001046 | 5 | 0.041 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.041 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.040 | |
| connective tissue development | GO:0061448 | 179 | 0.040 | |
| regulation of metanephric ureteric bud development | GO:2001074 | 1 | 0.040 | |
| oocyte development | GO:0048599 | 33 | 0.040 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.039 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.039 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.039 | |
| rna processing | GO:0006396 | 105 | 0.039 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.039 | |
| facial nerve structural organization | GO:0021612 | 10 | 0.039 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.039 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.039 | |
| rhombomere formation | GO:0021594 | 1 | 0.039 | |
| thorax and anterior abdomen determination | GO:0007356 | 1 | 0.039 | |
| oocyte differentiation | GO:0009994 | 35 | 0.038 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.038 | |
| renal tubule development | GO:0061326 | 87 | 0.038 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.038 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.038 | |
| rhombomere morphogenesis | GO:0021593 | 2 | 0.038 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.038 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.038 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.038 | |
| regulation of neuronal synaptic plasticity | GO:0048168 | 30 | 0.038 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.037 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.037 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.037 | |
| positive regulation of t cell differentiation | GO:0045582 | 52 | 0.037 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.037 | |
| rhombomere 5 morphogenesis | GO:0021664 | 1 | 0.037 | |
| response to peptide | GO:1901652 | 136 | 0.036 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.036 | |
| angiogenesis | GO:0001525 | 201 | 0.036 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.036 | |
| phagocytosis | GO:0006909 | 66 | 0.036 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.036 | |
| nuclear export | GO:0051168 | 34 | 0.035 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.035 | |
| epithelial tube formation | GO:0072175 | 130 | 0.035 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.035 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.035 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.035 | |
| lateral line nerve development | GO:0048892 | 1 | 0.034 | |
| sensory perception of umami taste | GO:0050917 | 4 | 0.034 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.034 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.034 | |
| positive regulation of macroautophagy | GO:0016239 | 3 | 0.034 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.034 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.034 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.034 | |
| facial nerve development | GO:0021561 | 11 | 0.034 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.034 | |
| mesonephros development | GO:0001823 | 97 | 0.034 | |
| heart contraction | GO:0060047 | 93 | 0.033 | |
| regulation of cell shape | GO:0008360 | 39 | 0.033 | |
| male sex differentiation | GO:0046661 | 109 | 0.033 | |
| fat cell differentiation | GO:0045444 | 160 | 0.033 | |
| regulation of secretion | GO:0051046 | 274 | 0.033 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.033 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.033 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.033 | |
| t cell differentiation | GO:0030217 | 174 | 0.033 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.033 | |
| mesenchyme development | GO:0060485 | 152 | 0.032 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.032 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.032 | |
| axonogenesis | GO:0007409 | 274 | 0.032 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.032 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.032 | |
| neural tube development | GO:0021915 | 160 | 0.032 | |
| hindbrain development | GO:0030902 | 128 | 0.032 | |
| locomotory behavior | GO:0007626 | 195 | 0.032 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.032 | |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 3 | 0.032 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.032 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.032 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.032 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.031 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.031 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.031 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.031 | |
| parasympathetic nervous system development | GO:0048486 | 19 | 0.031 | |
| gonad development | GO:0008406 | 141 | 0.030 | |
| regulation of metanephric glomerular mesangial cell proliferation | GO:0072301 | 1 | 0.030 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.030 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.030 | |
| innate immune response | GO:0045087 | 157 | 0.029 | |
| exocytosis | GO:0006887 | 121 | 0.029 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.029 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.029 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.029 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.029 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.029 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.029 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.029 | |
| response to radiation | GO:0009314 | 165 | 0.028 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.028 | |
| glomerular mesangial cell proliferation | GO:0072110 | 3 | 0.028 | |
| neuron projection guidance | GO:0097485 | 141 | 0.028 | |
| positive regulation of lymphocyte differentiation | GO:0045621 | 61 | 0.028 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.028 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.028 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.027 | |
| epithelial cell differentiation involved in kidney development | GO:0035850 | 23 | 0.027 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.027 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.027 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.027 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.027 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 3 | 0.027 | |
| proteoglycan metabolic process | GO:0006029 | 38 | 0.027 | |
| dna metabolic process | GO:0006259 | 303 | 0.027 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.027 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.027 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.027 | |
| negative regulation of reproductive process | GO:2000242 | 31 | 0.027 | |
| protein maturation | GO:0051604 | 176 | 0.027 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.027 | |
| cell adhesion | GO:0007155 | 329 | 0.026 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.026 | |
| regulation of ossification | GO:0030278 | 112 | 0.026 | |
| oogenesis | GO:0048477 | 56 | 0.026 | |
| protein polymerization | GO:0051258 | 57 | 0.026 | |
| positive regulation of mesonephros development | GO:0061213 | 20 | 0.026 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.026 | |
| segmentation | GO:0035282 | 93 | 0.026 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.026 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.026 | |
| synaptic vesicle transport | GO:0048489 | 57 | 0.026 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.025 | |
| regulation of gamma delta t cell activation | GO:0046643 | 9 | 0.025 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.025 | |
| nephron tubule development | GO:0072080 | 84 | 0.025 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.025 | |
| anatomical structure arrangement | GO:0048532 | 20 | 0.025 | |
| jnk cascade | GO:0007254 | 72 | 0.025 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.025 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.025 | |
| immune effector process | GO:0002252 | 321 | 0.025 | |
| blood circulation | GO:0008015 | 195 | 0.025 | |
| keratinocyte differentiation | GO:0030216 | 48 | 0.025 | |
| negative regulation of metanephros development | GO:0072217 | 6 | 0.025 | |
| lateral inhibition | GO:0046331 | 1 | 0.025 | |
| gamma delta t cell activation | GO:0046629 | 13 | 0.025 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.025 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.025 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.024 | |
| transcription from rna polymerase iii promoter | GO:0006383 | 3 | 0.024 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.024 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.024 | |
| necrotic cell death | GO:0070265 | 30 | 0.024 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.024 | |
| oocyte axis specification | GO:0007309 | 2 | 0.024 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.024 | |
| regulation of male gonad development | GO:2000018 | 7 | 0.024 | |
| organelle fission | GO:0048285 | 170 | 0.023 | |
| response to insulin | GO:0032868 | 100 | 0.023 | |
| translation | GO:0006412 | 93 | 0.023 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.023 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.023 | |
| oocyte maturation | GO:0001556 | 18 | 0.023 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.023 | |
| sensory perception | GO:0007600 | 245 | 0.023 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.023 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.023 | |
| respiratory tube development | GO:0030323 | 167 | 0.023 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.023 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.023 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.023 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.023 | |
| response to growth factor | GO:0070848 | 198 | 0.023 | |
| regulation of actin polymerization or depolymerization | GO:0008064 | 45 | 0.022 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.022 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.022 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 8 | 0.022 | |
| cognition | GO:0050890 | 149 | 0.022 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.022 | |
| regulation of t cell differentiation in thymus | GO:0033081 | 24 | 0.022 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.022 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.022 | |
| rap protein signal transduction | GO:0032486 | 3 | 0.022 | |
| cellular homeostasis | GO:0019725 | 240 | 0.022 | |
| tube closure | GO:0060606 | 91 | 0.022 | |
| positive regulation of growth | GO:0045927 | 104 | 0.022 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.022 | |
| cell differentiation involved in kidney development | GO:0061005 | 33 | 0.022 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.022 | |
| embryonic axis specification | GO:0000578 | 30 | 0.022 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.022 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.022 | |
| regulation of organ growth | GO:0046620 | 61 | 0.021 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.021 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.021 | |
| adaptive immune response | GO:0002250 | 155 | 0.021 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.021 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.021 | |
| synaptic vesicle localization | GO:0097479 | 59 | 0.021 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.021 | |
| syncytium formation | GO:0006949 | 43 | 0.021 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.021 | |
| neural tube formation | GO:0001841 | 108 | 0.021 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.021 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.021 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.021 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.021 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.021 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.021 | |
| kidney epithelium development | GO:0072073 | 121 | 0.021 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.021 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.021 | |
| female gonad development | GO:0008585 | 71 | 0.021 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.021 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.020 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.020 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.020 | |
| digestive system development | GO:0055123 | 200 | 0.020 | |
| establishment of synaptic vesicle localization | GO:0097480 | 57 | 0.020 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.020 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.020 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.020 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.020 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.020 | |
| integrin mediated signaling pathway | GO:0007229 | 27 | 0.020 | |
| regulation of integrin mediated signaling pathway | GO:2001044 | 8 | 0.020 | |
| circulatory system process | GO:0003013 | 197 | 0.020 | |
| response to purine containing compound | GO:0014074 | 28 | 0.020 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.020 | |
| kidney vasculature development | GO:0061440 | 15 | 0.020 | |
| cellular response to radiation | GO:0071478 | 28 | 0.020 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.019 | |
| metanephros development | GO:0001656 | 79 | 0.019 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.019 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.019 | |
| metanephric s shaped body morphogenesis | GO:0072284 | 2 | 0.019 | |
| ectoderm development | GO:0007398 | 15 | 0.019 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.019 | |
| rhythmic process | GO:0048511 | 174 | 0.019 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.019 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.019 | |
| cell division | GO:0051301 | 120 | 0.019 | |
| protein import into nucleus | GO:0006606 | 95 | 0.019 | |
| central nervous system segmentation | GO:0035283 | 3 | 0.019 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.019 | |
| cell cell junction organization | GO:0045216 | 72 | 0.019 | |
| sertoli cell development | GO:0060009 | 15 | 0.019 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.019 | |
| cranial nerve structural organization | GO:0021604 | 13 | 0.019 | |
| anion transport | GO:0006820 | 177 | 0.019 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.018 | |
| positive regulation of protein autophosphorylation | GO:0031954 | 4 | 0.018 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.018 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.018 | |
| dendrite development | GO:0016358 | 115 | 0.018 | |
| response to nutrient levels | GO:0031667 | 109 | 0.018 | |
| neuron death | GO:0070997 | 154 | 0.018 | |
| cytokinetic process | GO:0032506 | 2 | 0.018 | |
| regulation of binding | GO:0051098 | 111 | 0.018 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.018 | |
| midgut development | GO:0007494 | 4 | 0.018 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.018 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.018 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.018 | |
| notch signaling pathway | GO:0007219 | 71 | 0.018 | |
| transmembrane transport | GO:0055085 | 412 | 0.018 | |
| posterior mesonephric tubule development | GO:0072166 | 2 | 0.018 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.018 | |
| striated muscle cell development | GO:0055002 | 125 | 0.018 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.018 | |
